New implant aims to ease neck pain from disc disease
NCT ID NCT06155409
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 148 adults with cervical disc disease who received the Hexanium ACIF implant, a device placed between vertebrae to restore height and fuse the spine. Researchers will track pain, disability, and any serious side effects for up to 24 months after surgery. The goal is to confirm the implant is safe and works as intended.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hexanium ACIF implant (a cage placed between vertebrae to restore height and fuse the spine)
What this could lead to
If successful, this could confirm that the Hexanium ACIF implant is a safe and effective option for treating cervical disc disease, reducing pain and disability.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. Risks include infection, implant failure, or no improvement in symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERVERTEBRAL DISC DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU de Nancy
Nancy, 54000, France
-
Centre Hospitalier Privé de l'Europe
Le Port-Marly, 785620, France
-
Clinique du Dos Terrefort
Bordeaux, 33520, France
-
Hôpital Privé du Dos Francheville
Périgueux, 24000, France
-
Hôpital Robert Schuman - UNEOS
Vantoux, 57070, France
-
Polyclinique Majorelle
Nancy, 54000, France